Bausch Health Companies (BHC) Other Accumulated Expenses (2010 - 2012)
Bausch Health Companies (BHC) posted Other Accumulated Expenses of $109.4 million for Q4 2012, up 127.78% sequentially from $48.0 million in Q4 2011, and up 127.78% YoY from $48.0 million in Q1 2012.
Bausch Health Companies (BHC) Other Accumulated Expenses (2010 - 2012) Analysis & Trends
Bausch Health Companies has reported Other Accumulated Expenses for 3 years, with the latest figure at $109.4 million in Q4 2012.
- Quarterly Other Accumulated Expenses rose 127.78% year-over-year to $109.4 million in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $109.4 million (up 127.78% YoY) and the FY2012 annual result came in at $109.4 million, up 127.78% from the prior year.
- Other Accumulated Expenses climbed to $109.4 million in Q4 2012 per BHC's latest filing, from $48.0 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $109.4 million in Q4 2012 and troughed at $48.0 million in Q4 2011.
- A 3-year average of $72.2 million and a median of $59.2 million in 2010 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2011 and 2012: Other Accumulated Expenses slipped 18.88% in 2011, then soared 127.78% in 2012.
- Over 3 years, Other Accumulated Expenses stood at $59.2 million in 2010, then retreated by 18.88% to $48.0 million in 2011, then jumped by 127.78% to $109.4 million in 2012.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $109.4 million, $48.0 million, and $59.2 million for Q4 2012, Q4 2011, and Q4 2010 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 24.52 Mn |
| Dec 31, 2011 | 9.59 Mn |
| Dec 31, 2010 | 59.22 Mn |